Hayley Jankowski has been interested in biomedical research since her freshman year of high school. Now, the Rowan University ...

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative ...

Home > Press release: Miniature Hearts: Cardiac Organoids With ...

Mesoblast Limited’s FDA-approved Ryoncil and advancing Revascor target major conditions like SR-aGVHD and heart failure. See ...

Netta Blondheim-Shraga, PhD, Senior Vice President of Research & Development at BrainStorm, will present new insights into ...

At its third attempt, Mesoblast has secured FDA approval for Ryoncil as a treatment for children with graft-versus-host disease, the first-ever approval for a mesenchymal stromal cell (MSC ...

Dental caries (tooth decay) is a common oral health condition that often causes significant pain and discomfort and may even ...

As, that fuels belly fat growth in middle age, offering a target for therapies to combat age-related obesity and disease.

Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies ...

In this valuable study, the authors demonstrate that TCF7L2 plays a role in the pathogenesis of cachexia in a mouse model of GI cancer. The results are solid, although future studies will need further ...